Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Data availability Data is provided within the manuscript
Dulaglutide treatment reverses depression-like behavior and hippocampal metabolomic homeostasis in mice exposed to chronic mild stress
Yadav, H., Lee, J
Published 2021 Jul 7
If eligible, receive a clinically developed and FDA-approved weight loss and prescription medication plan, insurance coordination, and ongoing support
Last month, Viking Therapeutics posted promising Phase I data for its oral obesity candidate VK2735, achieving a 3.3% drop in mean body weight against a placebo with a p-value of 0.0006
US$ 21.67
US$ 23.49
US$ 26.62
